| Specialty Retail Industry | Consumer Discretionary Sector | Mr. Jeong-Chool Kim CEO | KRX SM Exchange | KR7003060001 ISIN |
| KR Country | 391 Employees | - Last Dividend | 13 Apr 2026 Last Split | - IPO Date |
Aprogen Biologics Inc. is a South Korean pharmaceutical company, established in 1960, with its headquarters located in Seongnam-si. The company is engaged in the manufacture and sale of a diverse portfolio of pharmaceutical products within the local market. It prides itself on offering a wide range of medicines, spanning both ethical (prescription) drugs and over-the-counter (OTC) treatments, catering to various medical needs and conditions. With a focus on innovation and excellence in the pharmaceutical field, Aprogen Biologics Inc. is committed to improving patient care and health outcomes.
Aprogen Biologics Inc.’s product lineup covers a vast range of therapeutic areas, including: